Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.
- Status
- TERMINATED
- Phase
- PHASE3
Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Status
- SUSPENDED
- Phase
- PHASE2
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bexarotene in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Amonafide in Combination With Cytarabine in Secondary AML
- Status
- COMPLETED
- Phase
- PHASE2
Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Decitabine in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
- Status
- COMPLETED
- Phase
- PHASE2
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE2